University of Ottawa logo
CHLPE logo

Past Event Videos

June 18, 2021

Key Policy Issues in Organ Donation & Transplantation – 6. ODT and COVID-19

Marie-Chantal Fortin
Nephrologist
/
Principal Scientist – Immunopathology
Centre hospitalier de l'Université de Montréal

Simon Oczkowski
Intensivist
/
Professor, Faculty of Health Sciences
McMaster University

Sean Delaney
Patient Partner
/
Associate Director, Organ Listing & Allocation
Canadian Blood Services

Maxwell J. Smith
Professor, School of Health Studies
Western University
/
Member, Ontario COVID-19 Vaccine Distribution Task Force

June 18, 2021

Key Policy Issues in Organ Donation & Transplantation – 7. Alcohol Abstinence

Prosanto Chaudhury
Interim Director, Multi-Organ Transplant Program
McGill University Health Centre

Susan Abbey
Psychiatrist-in-Chief
University Health Network (Toronto)

Alyssa Tomkins
Partner
Caza Saikaley LLP

June 18, 2021

Key Policy Issues in Organ Donation & Transplantation – 8. Big Data And Machine Learning

Michaël Chassé
Intensivist
/
Principal Scientist – Innovation
Centre hospitalier de l'Université de Montréal

Heloïse Cardinal
Transplant Nephrologist
/
Principal Scientist – Immunopathology
Centre hospitalier de l'Université de Montréal

Glenn Cohen
Professor
/
Deputy Dean
Harvard Law School, U.S.A.

June 18, 2021

Key Policy Issues in Organ Donation & Transplantation – 9. Reform of the Canadian ODT System

Sam Shemie
Critical Care Pediatrician
Hôpital de Montréal pour enfants / McGill University Health Centre

Caroline Tait
Medical Anthropologist, Department of Psychiatry
University of Saskatchewan

Katherine Fierlbeck
Professor, Political Science
Dalhousie University

Patrick Fafard
Professor, Public and International Affairs
University of Ottawa Centre for Health Law, Policy and Ethics

June 1, 2021

L’internement psychiatrique : pratiques et recherches

Ce séminaire cherchera à faire le point sur l’état des pratiques et de la recherche en matière d’internement dans quatre juridictions, soit la Suisse, la Belgique, la France et le Québec. Les présentations seront organisées autour de trois questions : 1- l’approche socio-historique de la législation et des dispositifs mis en place (les sources du système), 2- les derrières réformes et leurs objectifs (l'état actuel) et 3- les constats de terrain et les enjeux en pratique et pour la recherche.

Cristina Ferreira
Sociologue et professeure associée
Haute Ecole de santé Vaud (HESAV) Lausanne (Suisse)

Shirin Hatam
Avocate (Suisse)

Yves Cartuyvels
Vice-recteur à la recherche
Université Saint-Louis-Bruxelles (Belgique)

Sophie De Spiegeleir
Sociologue et anthropologue de formation
Université Saint-Louis-Bruxelles (Belgique)

Mathias Couturier
Maître de conférences en droit privé et sciences criminelles
Université de Caen Normandie (France)

Emmanuelle Bernheim
Professeure titulaire
Faculté de droit (Section de droit civil)
Université d’Ottawa (Canada)

Jennifer Chandler
Professeure titulaire
Faculté de droit (Section common law)
Université d’Ottawa (Canada)

May 18, 2021

Do Courts Care About Health Technology Assessment?

Daniel Wang
Associate Professor, Fundação Getúlio Vargas School of Law (Sao Paulo, Brazil)

Natália Pires de Vasconcelos
Assistant Professor of Law, Insper (Sao Paulo, Brazil)

Mathieu Poirier
Assistant Professor of Social Epidemiology, 
York University

Steven J. Hoffman
Scientific Director, CIHR Institute of Population & Public Health

February 25, 2021

Death and the Brain

Thaddeus Mason Pope
Mitchell Hamline School of Law, USA

January 14, 2021

Le risque dans les politiques, le droit et les pratiques en psychiatrie

Emmanuelle Bernheim
Faculté de droit – Section de droit civil
Université d’Ottawa

Jean-Daniel Jacob
École des sciences infirmières
Université d’Ottawa

December 7, 2020

AI in Healthcare

Anna Goldenberg
Sickkids Research Institute

Colleen M. Flood
Director, CHLPE

November 18, 2020

Futility Disputes at the End of Life

Daphne Jarvis
Partner
Borden Ladner Gervais LLP

James Downar
Médecin (Critical Care / Palliative Care)
The Ottawa Hospital

November 13, 2020

Virtual Naloxone Training Session

Mark Barnes
Respect Rx Pharmacies
naloxonecare.com

November 13, 2020

The Impact of COVID-19 on Harm Reduction

Impact of COVID-19 on harm reduction efforts to address overdose: Developments and continuing challenges
/
Food security as harm reduction in times of COVID-19 and beyond
/
We are not in this together, We never have been

Gillian Kolla
Post-Doctoral Fellow
Canadian Institute for Substance Use Research
University of Victoria

Callie Lathem
Harm Reduction Worker and Health Promoter
Somerset West Community Health Centre (Ottawa)

Zoë Dodd
Co-Organizer
Toronto Overdose Prevention Society

November 13, 2020

Harm Reduction at the Front Lines

Normalizing and securing SCS in Canada
/
Harm reduction services in Ottawa: The culture of drug use
/
Criminalized and pathologized: The ethical tensions of harm reduction case management when supporting people who use drugs in acute mental distress
/
The moral economy of the movement for overdose prevention sites: Civil society and the management of the opioid “crisis”
/
Pillars before purpose: Has stigma affected the language of the four pillars?

Richard Elliott
Executive Director
HIV Legal Network

Marlene Haines
Doctoral Student, Nursing
University of Ottawa

Kourteney King
M.A. Student, Adult Education and Community Development
University of Toronto

Thomas Foth
Professor, Nursing
University of Ottawa

Gord Garner
Executive Director
Community Addictions Peer Support Association

November 13, 2020

Harm Reduction and Indigenous Peoples

Preventing perverse effects of tobacco control is also harm reduction – How New Zealand’s tobacco control programme helps but also harms the indigenous Maori people
/
Indigenous harm reduction = Reducing the harms of colonization

Marewa Glover
Director, Centre of Research Excellence – Indigenous Sovereignty & Smoking (New Zealand)

Tracey Prentice
Research Fellow, Public Health and Social Policy
University of Victoria

Trevor Stratton
Coordinator
International Indigenous Working Group on HIV & AIDS

November 13, 2020

Nicotine Regulation and Interfaces with Harm Reduction

Regulating modified risk claims under the Canada Tobacco and Vaping Products Act and the U.S. Family Smoking Prevention and Tobacco Control Act
/
Vaping: Policy reactions in panicked times
/
The ethics of tobacco harm reduction: An analysis of e-cigarette availability from the perspectives of utilitarianism, bioethics, and public health ethics

Sam Halabi
Professor, Law
University of Missouri

Amelia Howard
Doctoral Student, Sociology
University of Waterloo

Saul Shiffman
Professor, Psychology
University of Pittsburgh

November 12, 2020

Harm Reduction – Drug Regulation Policies and Strategies

Decriminalizing simple possession of drugs and harm reduction strategies
/
Problematizing safe consumption sites: A discourse analysis of Ontario’s consumption treatment site policy
/
Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19: The potential roles for safe supply and decriminalization

Line Beauchesne
Professor, Criminology
University of Ottawa

Stephanie Arlt
M.Sc. Student, Social Dimensions of Health
University of Victoria

Matt Bonn
Program Coordinator
Canadian Association of People Who Use Drugs (CAPUD)